← FDA Drug Approvals (Drugs@FDA)

EXBLIFEP

NDA · New Drug Application · Sponsor: ORCHID PHARMA · Approved 2024-02-22

Drug application

FDA Application #

NDA216165

Application type

New Drug Application

Brand name

EXBLIFEP

Generic name

Cefepime Hydrochloride

Active ingredients

CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

ORCHID PHARMA

First approval

2024-02-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown